RCUS · Arcus Biosciences, Inc. · Webcasts, Transcripts & Audio
$17.43
-0.34 (-1.91%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$2.51B
Shares
143.99M
Volume · Nov 13
1.14M
Avg daily vol (3M)
1.84M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Arcus Biosciences, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Arcus Biosciences, Inc. (RCUS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-16
Arcus Biosciences, Inc. (RCUS) November 16, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-04
Arcus Biosciences, Inc. (RCUS) Q3 2026 Earnings Call
Revenue
$9.00M
▼ 65.4% YoY Diluted EPS
$-1.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Investor Update
Investor event
2026-10-20
Arcus Biosciences, Inc. (RCUS) October 20, 2026 Investor Update Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-15
Arcus Biosciences, Inc. (RCUS) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-09
Arcus Biosciences, Inc. (RCUS) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-05
Arcus Biosciences, Inc. (RCUS) Q2 2026 Earnings Call Transcript
Confident tone
Belzutafan durability and HIF2 mechanism thesis
ARC-20 platform study and data readouts
Competitive positioning after LightSpark 012 failure
Revenue
$41.00M
▼ 74.4% YoY Diluted EPS
$-0.72
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Arcus Biosciences, Inc. (RCUS) June 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Arcus Biosciences, Inc. (RCUS) Q1 2026 Earnings Call Transcript
Confident tone
Cascadifan lead program and differentiation
Frontline RCC strategy and combinations
PEEK-1 Phase 3 enrollment and timeline
Revenue
$17.00M
▼ 39.3% YoY Diluted EPS
$-1.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-09
Arcus Biosciences, Inc. (RCUS) March 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-25
Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript
Confident tone
Frontline TKI-sparing strategy
Casdatifan HIF2a inhibitor differentiation
Peak One Phase 3 in IO-experienced RCC
Revenue
$33.00M*
▲ 26.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-01-14
Arcus Biosciences, Inc. (RCUS) January 14, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-08-06
Arcus Biosciences, Inc. (RCUS) Q2 2025 Earnings Call
Revenue
$160.00M
▲ 310.3% YoY Diluted EPS
$0.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Arcus Biosciences, Inc. (RCUS) Q1 2025 Earnings Call Transcript
Confident tone
Casdatifan (cas) program prioritization
ASCO oral presentation and data flow
Casdatifan combinations and earlier-line opportunity
Revenue
$28.00M
▼ 80.7% YoY Diluted EPS
$-1.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Arcus Biosciences, Inc. (RCUS) Q4 2024 Earnings Call
Revenue
$26.00M*
▼ 16.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Arcus Biosciences, Inc. (RCUS) Q3 2024 Earnings Call Transcript
Confident tone
Dom Zim Phase 3 trials (STAR-121, STAR-221, Pacific-8)
ARC-20 study data updates and future readouts
Domvanalimab (Fc-silent anti-TIGIT) and ARC-10 data
Revenue
$48.00M
▲ 50% YoY Diluted EPS
$-1.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Arcus Biosciences, Inc. (RCUS) Q2 2024 Earnings Call
Revenue
$39.00M
▲ 34.5% YoY Diluted EPS
$-1.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Arcus Biosciences, Inc. (RCUS) Q1 2024 Earnings Call Transcript
Confident tone
Casdatifan (cas) in clear cell RCC vs. Novartis HIF-2
Quemliclustat (quemli) in pancreatic cancer
ASCO 2024 oral presentations and upcoming catalysts
Revenue
$145.00M
▲ 480% YoY Diluted EPS
$-0.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Arcus Biosciences, Inc. (RCUS) Q4 2023 Earnings Call Transcript
Confident tone
Casdatifan (AB521) HIF-2alpha inhibitor
Anti-TIGIT (domvanalimab/zimberelimab, dom/zim) program
Quemliclustat (quemli) CD73 inhibitor in pancreatic cancer
Revenue
$31.00M*
▼ 8.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Arcus Biosciences, Inc. (RCUS) Q3 2023 Earnings Call Transcript
Revenue
$32.00M
▼ 3% YoY Diluted EPS
$-0.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Arcus Biosciences, Inc. (RCUS) Q2 2023 Earnings Call
Revenue
$29.00M
▲ 7.4% YoY Diluted EPS
$-1.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Arcus Biosciences, Inc. (RCUS) Q1 2023 Earnings Call
Revenue
$25.00M
▲ 38.9% YoY Diluted EPS
$-1.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Arcus Biosciences, Inc. (RCUS) Q4 2022 Earnings Call
Revenue
$34.00M*
▼ 90.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Arcus Biosciences, Inc. (RCUS) Q3 2022 Earnings Call
Revenue
$33.00M
▲ 248.8% YoY Diluted EPS
$-0.90
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Arcus Biosciences, Inc. (RCUS) Q2 2022 Earnings Call
Revenue
$27.00M
▲ 185.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Arcus Biosciences, Inc. (RCUS) Q1 2022 Earnings Call
Revenue
$18.00M
▲ 90.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Arcus Biosciences, Inc. (RCUS) Q4 2021 Earnings Call
Revenue
$354.62M*
▲ 3637.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-18
Arcus Biosciences, Inc. (RCUS) Q3 2021 Earnings Call
Revenue
$9.46M
▼ 85.3% YoY Diluted EPS
$-1.11
▼ 3800% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Arcus Biosciences, Inc. (RCUS) Q2 2021 Earnings Call Transcript
Revenue
$9.46M
▲ 440.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–28 of 28 webcasts
Key facts
CIK
1724521
CUSIP
03969F109
13F (30d)
174 filings
158 filers
Visit website
Investor relations